207 related articles for article (PubMed ID: 32076049)
1. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis.
Zhou C; Yao Q; Zhang H; Guo X; Liu J; Shi Q; Huang S; Xiong B
Sci Rep; 2020 Feb; 10(1):2964. PubMed ID: 32076049
[TBL] [Abstract][Full Text] [Related]
2. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
3. Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways.
Song J; Guan Z; Song C; Li M; Gao Z; Zhao Y
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846786
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
[TBL] [Abstract][Full Text] [Related]
5. Rational design of temperature-sensitive blood-vessel-embolic nanogels for improving hypoxic tumor microenvironment after transcatheter arterial embolization.
Li L; Liu Y; Li H; Guo X; He X; Geng S; Zhao H; Peng X; Shi D; Xiong B; Zhou G; Zhao Y; Zheng C; Yang X
Theranostics; 2018; 8(22):6291-6306. PubMed ID: 30613298
[TBL] [Abstract][Full Text] [Related]
6. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
7. Apatinib-loaded CalliSpheres Beads for embolization in a rabbit VX2 liver tumor: characterization
Shi Q; Lu Y; Huang S; Zhou C; Yang C; Liu J; Ma J; Xiong B
Drug Deliv; 2020 Dec; 27(1):1301-1307. PubMed ID: 32924634
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA MIAT knockdown potentiates the therapeutic effect of transcatheter arterial embolization in liver cancer by regulating the miR‑203a/HIF‑1α axis.
Liu J; Cao G; Liu J; Zhao X; Cao H
Oncol Rep; 2020 Aug; 44(2):722-734. PubMed ID: 32468055
[TBL] [Abstract][Full Text] [Related]
9. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
Matsuo N; Uchida H; Nishimine K; Soda S; Oshima M; Nakano H; Nagano N; Nishimura Y; Yoshioka T; Guo Q
J Vasc Interv Radiol; 1993; 4(4):543-9. PubMed ID: 8394758
[TBL] [Abstract][Full Text] [Related]
10. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
11. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
12. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
13. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
[TBL] [Abstract][Full Text] [Related]
15. IL-17 predicts the effect of TACE combined with apatinib in hepatocellular carcinoma.
Wu Y; Cheng G; Chen H; Wang J; Wang J; Wang W
Clin Hemorheol Microcirc; 2021; 77(1):37-47. PubMed ID: 32651310
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Kim YI; Lee KH; Jeong JM; Paeng JC
J Vasc Interv Radiol; 2004 Oct; 15(10):1121-8. PubMed ID: 15466799
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study.
Yang Z; Chen G; Cui Y; Xiao G; Su T; Yu J; Zhang Z; Han Y; Yang K; Jin L
Cancer Biol Ther; 2019; 20(3):321-327. PubMed ID: 30332553
[TBL] [Abstract][Full Text] [Related]
18. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe.
Terayama N; Miyayama S; Tatsu H; Yamamoto T; Toya D; Tanaka N; Mitsui T; Miura S; Fujisawa M; Kifune K; Matsui O; Takashima T
J Vasc Interv Radiol; 1998; 9(3):501-8. PubMed ID: 9618113
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Higuchi T; Kikuchi M; Okazaki M
Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
[TBL] [Abstract][Full Text] [Related]
20. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
